Atrium Therapeutics
RNA • NASDAQ • Stock Fundamentals
Atrium Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Kathleen Gallagher, with a market cap of $223.4M.
Market Cap$223.4M
Employees253.0
CEOKathleen Gallagher
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026
View reportFinancials
Based on Q1 2026 filing
Atrium Therapeutics FAQ
Common questions about Atrium Therapeutics
Atrium Therapeutics (RNA) has a market capitalization of $223.4M and trades on NASDAQ.
Atrium Therapeutics has approximately 253 employees.